Total Payments
$48,781
2024 Payments
$1,540
Companies
2
Transactions
95
Medicare Patients
2,007
Medicare Billing
$255,233
Payment Breakdown by Category
Consulting$46,779 (95.9%)
Travel$1,037 (2.1%)
Other$950.00 (1.9%)
Food & Beverage$14.73 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $46,779 | 88 | 95.9% |
| Travel and Lodging | $1,037 | 5 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $950.00 | 1 | 1.9% |
| Food and Beverage | $14.73 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $48,766 | 94 | $0 (2024) |
| Genentech USA, Inc. | $14.73 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,540 | 4 | Novartis Pharmaceuticals Corporation ($1,540) |
| 2023 | $4,547 | 7 | NOVARTIS PHARMACEUTICALS CORPORATION ($4,547) |
| 2022 | $16,750 | 31 | Novartis Pharmaceuticals Corporation ($16,750) |
| 2021 | $19,501 | 40 | NOVARTIS PHARMACEUTICALS CORPORATION ($19,501) |
| 2020 | $5,678 | 11 | Novartis Pharmaceuticals Corporation ($5,678) |
| 2019 | $750.00 | 1 | Novartis Pharmaceuticals Corporation ($750.00) |
| 2017 | $14.73 | 1 | Genentech USA, Inc. ($14.73) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 01/04/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $250.00 | General |
| Category: Neurology | ||||||
| 01/04/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $175.61 | General |
| Category: Neurology | ||||||
| 01/04/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $164.15 | General |
| Category: Neurology | ||||||
| 04/15/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 04/15/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Neurology | ||||||
| 04/15/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $283.62 | General |
| Category: Neurology | ||||||
| 04/15/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $163.80 | General |
| Category: Neurology | ||||||
| 03/16/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 02/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 02/03/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 11/30/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $6.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $215.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $184.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $36.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $2.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 479 | 1,862 | $168,057 | $66,874 |
| 2022 | 7 | 388 | 641 | $128,688 | $50,576 |
| 2021 | 7 | 614 | 961 | $190,279 | $75,118 |
| 2020 | 6 | 526 | 818 | $158,979 | $62,665 |
Total Patients
2,007
Total Services
4,282
Medicare Billing
$255,233
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 64 | 220 | $45,993 | $17,733 | 38.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 90 | 116 | $41,230 | $16,355 | 39.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 46 | 75 | $11,433 | $5,675 | 49.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 49 | 52 | $13,466 | $5,152 | 38.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 75 | 87 | $12,959 | $5,049 | 39.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 31 | 35 | $11,577 | $4,864 | 42.0% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 20 | 30 | $9,031 | $3,439 | 38.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 36 | 63 | $6,798 | $3,065 | 45.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 27 | 48 | $7,041 | $2,761 | 39.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 14 | 19 | $4,976 | $1,548 | 31.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 16 | 17 | $2,454 | $1,106 | 45.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 11 | 1,100 | $1,100 | $127.87 | 11.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 65 | 202 | $36,150 | $14,247 | 39.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 83 | 96 | $31,240 | $12,409 | 39.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 42 | 88 | $11,952 | $4,680 | 39.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 67 | 74 | $11,387 | $4,470 | 39.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 30 | 45 | $8,053 | $3,027 | 37.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 35 | 37 | $7,566 | $2,991 | 39.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 18 | 19 | $6,183 | $2,430 | 39.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 16 | 22 | $5,804 | $2,293 | 39.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 13 | 21 | $5,327 | $2,088 | 39.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 19 | 37 | $5,025 | $1,941 | 38.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 127 | 316 | $56,865 | $22,860 | 40.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 151 | 172 | $56,642 | $22,683 | 40.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 90 | 192 | $26,202 | $10,458 | 39.9% |
About Dr. Rex Hudson, MD
Dr. Rex Hudson, MD is a General Practice healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235113325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rex Hudson, MD has received a total of $48,781 in payments from pharmaceutical and medical device companies, with $1,540 received in 2024. These payments were reported across 95 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($46,779).
As a Medicare-enrolled provider, Hudson has provided services to 2,007 Medicare beneficiaries, totaling 4,282 services with total Medicare billing of $255,233. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Saint Louis, MO
- Active Since 12/01/2005
- Last Updated 12/15/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235113325
Products in Payments
- GILENYA (Drug) $39,623
- MAYZENT (Drug) $9,143
- Activase (Biological) $14.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Saint Louis
Dr. Peter Panagos, Md, MD
General Practice — Payments: $97,272
General Practice $97,272
Dr. Jeremy Pfeffer, D.m.d, D.M.D
General Practice — Payments: $16,456
General Practice $16,456
Dr. Johnathan Miller, Md, MD
General Practice — Payments: $13,202
General Practice $13,202
Dr. Mark Mcclure, Dds, DDS
General Practice — Payments: $12,725
General Practice $12,725
Dr. Sable Muntean, Dmd, Mhsa, DMD, MHSA
General Practice — Payments: $12,233
General Practice $12,233
Seth Wasson, Dmd, DMD
General Practice — Payments: $10,228
General Practice $10,228